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Background: The M2 -herpesvirus protein exploits B cell signaling pathways to promote viral latency.
Results:M2 binds several SH2- and SH3-containing signaling proteins using phosphotyrosinemotifs and a proline-rich region,
respectively.
Conclusion: These interactions affect the juxtamembranar localization of M2 as well as downstream signaling events.
Significance:M2 may be used as a model to understand modulation of B cells by -herpesvirus infection.
-Herpesviruses express proteins that modulate B lympho-
cyte signaling to achieve persistent latent infections. One such
protein is the M2 latency-associated protein encoded by the
murid herpesvirus-4. M2 has two closely spaced tyrosine resi-
dues, Tyr120 and Tyr129, which are phosphorylated by Src family
tyrosine kinases.Hereweusedmass spectrometry to identify the
binding partners of tyrosine-phosphorylated M2. Each M2
phosphomotif is shown to bind directly and selectively to SH2-
containing signaling molecules. Specifically, Src family kinases,
NCK1 and Vav1, bound to the Tyr(P)120 site, PLC2 and the
SHP2 phosphatase bound to the Tyr(P)129 motif, and the p85
subunit of PI3K associated with either motif. Consistent with
these data, we show that M2 coordinates the formation of mul-
tiprotein complexes with these proteins. The effect of those
interactions is functionally bivalent, because it can result in
either the phosphorylation of a subset of binding proteins (Vav1
and PLC2) or in the inactivation of downstream targets (AKT).
Finally,we show that translocation to theplasmamembrane and
subsequent M2 tyrosine phosphorylation relies on the integrity
of a C-terminal proline-rich SH3 binding region of M2 and its
interaction with Src family kinases. Unlike other -herpesvi-
ruses, that encode transmembrane proteins that mimic the
activation of ITAMs, murid herpesvirus-4 perturbs B cell sig-
naling using a cytoplasmic/membrane shuttling factor that
nucleates the assembly of signaling complexes using a bilay-
ered mechanism of phosphotyrosine and proline-rich
anchoring motifs.
The MuHV-45 and its human -herpesvirus counterparts,
the EBV and Kaposi sarcoma-associated herpesvirus, establish
persistent latent infections in memory B cells. To access the
memory B cell compartment, these viruses encode proteins
that interfere with B cell signaling pathways leading to activa-
tion, differentiation, and survival (1). Some of these proteins are
thought to drive the proliferation of latently infected B cells in
germinal center reactions, which are the site of activation and
differentiation of B cells followingB cell receptor stimulation by
antigen. By driving germinal center reactions, -herpesvirus
amplify infection and gain physiological access to memory B
cells to achieve effective host colonization.
Binding of antigen to theBCR leads to the phosphorylation of
ITAMs located in the cytoplasmic tails of the BCR complex.
This is carried out by Src family kinases Lyn, Fyn, and BLK and
generates phospho-ITAMs that recruit the Syk tyrosine kinase.
Phosphorylation cascades triggered by the kinases lead to the
assembly of a complex containing adaptor proteins and
enzymes, such asVav1, PLC2, and PI3K (2). Signals emanating
from this signalosome lead to B cell activation.
Examples of -herpesvirus proteins that either mimic or
interfere with BCR signaling are the LMP1 and LMP2A
encoded by the EBV and K1 and K15 encoded by the Kaposi
sarcoma-associated herpesvirus (1). These transmembrane
molecules harbor in their cytoplasmic tails protein interaction
motifs that mediate the assembly of specific signalosomes. For
example, the K1 cytoplasmic domain contains a constitutively
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phosphorylated ITAM that recruits the SH2-containing pro-
teins Lyn, Syk, p85, PLC2, and Vav1, thus promoting the
engagement of signaling cascades similar to those triggered
upon BCR stimulation (3).
The MuHV-4 does not encode proteins with sequence simi-
larity to such transmembrane proteins (4). By contrast, the
unique latency-associated M2 protein fromMuHV-4 has been
identified as an adaptor protein that modulates B cell signaling
and is potentially a functional homologue of the aforemen-
tioned viral proteins (5, 6). M2 expression drives B cell prolif-
eration in vitro (7), and in a mouse model of infection, M2 is
required for the entry of latently infected B cells into germinal
center reactions (5, 8–10).
M2 is a 192-amino acid-long proline-rich protein localizing
to the nucleus and juxtamembranar areas of the cell (6, 9, 11).
M2 binds the SH3 domains of several cellular proteins (6). A
C-terminal PRR (residues 153–171) (Fig. 1A) containing a con-
sensus class I SH3 binding motif, binds directly to the C-termi-
nal SH3 domain of Vav1 andmodulates association of M2 with
Vav1 and Fyn in cells (6). In addition, M2 contains two motifs
encompassingTyr120 andTyr129 that are differentially and con-
stitutively phosphorylated by Src family kinases (5, 6). The
C-terminal SH3-binding PRR is required for phosphorylation
of M2, but the mechanism underlying this requirement is
unknown. Efficient entry of MuHV-4-infected B cells in germi-
nal center reactions depends on the C-terminal PRR and
phosphomotifs present in M2 (5, 12).
The sequence encompassing Tyr120 and Tyr129 does not
form a consensus ITAM (Fig. 1A). The Tyr(P)120 motif binds
the SH2 domains of Vav1 and Fyn (5). This phosphomotif and
the C-terminal PRRmediate assembly of a M2-Fyn-Vav1 com-
plex that results in the phosphorylation of Vav1 by Fyn and its
catalytic activation (5, 6). M2 expression in B cells drives tyro-
sine phosphorylation of other proteins in the molecular mass
range of 50 to 150 kDa, suggesting that M2 may assemble a
larger signalosome (5). Given the relative promiscuity in
Tyr(P)-SH2domain interactions, theTyr(P)120motif and the so
far uncharacterized Tyr(P)129 motif could be targeting other
SH2 domains.
In this study, we identify new partners of tyrosine-phosphor-
ylated M2 and show that both phosphomotifs are functional,
independent SH2 binding sites with different specificities for B
cell signaling molecules. M2 is also shown to have an effect in
two of the newly identified cellular targets. Specifically, M2
expression drove tyrosine phosphorylation of PLC2 and
inhibited AKT activation upon BCR stimulation. Finally, the
role of the C-terminal PRR of M2 was further investigated. We
show that this region of M2 binds strongly to the SH3 domains
of Lyn and Fyn and directs M2 to juxtamembranar areas of B
cells.
EXPERIMENTAL PROCEDURES
Plasmids—pCMV-myc plasmids encoding wild type M2,
M2Y, Y120F, Y129F, and M2P2 proteins have been described
(5, 6). To express proteins with an N-terminal enhanced GFP
(eGFP), DNA encoding wild type and mutant M2 proteins was
cloned into pEGFP-C plasmids (Clontech). The cDNA encod-
ing the PH domain of AKT was subcloned from GFP-PH-AKT
(a gift from Dr T. Meyer (Stanford University)) into
pmCherry-C1 (Clontech). The cDNA encoding full-length
PLC2 (pMT2-PLC2; a gift from Dr. M. Katan (Institute of
Cancer Research, London)) was cloned into pCMV-HA (Clon-
tech). Tyrosine to phenylalaninemutations in PLC2were gen-
eratedwith theQuikChangemultisite-directedmutagenesis kit
(Stratagene). pGEXFyn SH2 (aa 145–247) and pGEXVav1 SH2
(aa 655–774) have been described (5, 13). The DNA sequence
encoding the SH2 domains of Lyn (aa 128–226) and NCK1 (aa
281–377) and the N- and C-terminal SH2 domains (termed
SH2 N and SH2 C hereafter) of PLC2 (SH2 N, aa 532–635;
SH2 C, aa 641–674), p85 (SH2 N, aa 332–428; SH2 C, aa
617–724), and SHP2 (tyrosine-protein phosphatase non-recep-
tor 11) (SH2N, aa 6–102; SH2 C, aa 111–216) was amplified by
PCR and cloned into pGEX vectors (GE Healthcare). To
express N-terminal His6-tagged SH3 proteins, the DNA encod-
ing the SH3 domains of PLC2 (aa 769–829) and p85 (aa
1–85), the C-terminal SH3 domain of Vav1 (aa 785–842), and
the SH3 domain 1 (aa 1–61), 2 (aa 108–165), and 3 (aa 188–
252) of NCK1 was cloned into the pQlink H vector (14). DNA
encoding the SH3 domains of Fyn (aa 81–144) and Lyn (aa
63–124) and wild type M2 were cloned into pGEX 6P-1. All
constructs were confirmed by DNA sequencing.
Pull-down Experiments—For pull-down of cellular proteins
with M2 Tyr(P) peptides, 1 108 or 2 108 cells of the Raji B
cell line or 5 108 COS1 cells were washed with PBS and lysed
with ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, 100 mM
NaCl, 1%TritonX-100, 1mMNaVO4, 1mMNaF, andComplete
EDTA-free protease inhibitors). Lysates were cleared by cen-
trifugation, and the supernatants were incubated with strepta-
vidin-conjugated Sepharose beads (GE Healthcare) for 4 h at
4 °C. Supernatants were filtered through a 0.45-mmembrane
and incubated with 15g of pY120 or pY129 (Fig. 1A) (5) over-
night at 4 °C. Peptide complexes were captured with streptavi-
din-Sepharose beads. After washing with lysis buffer, proteins
were eluted with Laemmli’s buffer and resolved on 10% SDS-
polyacrylamide gels. Gels were fixed with a 45%methanol, 10%
acetic acid solution, for 20 min at room temperature and
stained with SYPRO Ruby (Molecular Probes). Individual
bands (Fig. 1, B and C) were excised and processed forMS (15).
Binding of SH2 domains to pY120 and pY129 was assessed by
pull-down as described (5). Binding of GST-M2 fusion to His-
tagged SH3 domains was assessed by GST pull-down assay.
MALDI-TOF MS—Tryptic peptides were analyzed by
MALDI-TOF (Ultraflex, Bruker). Identification of protein
bands was performed by comparison of the results with the
Swiss-Prot database using the MASCOT algorithm (16).
Antibodies—Anti-c-Myc (9E10) was from Clontech. The
anti-Tyr(P) (PY99) mAb and anti-PLC2 (Q-20), anti-Vav1
(C-14), anti-SH-PTP2 (C-18), anti-Fyn (FYN3), anti-AKT
(N-19), and anti-HA (Y-11) polyclonal antibodies were from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-GFP
and anti-GST polyclonal antibodies were from Abcam and GE
Healthcare, respectively. The anti-p85 polyclonal antibody
was from Upstate Cell Signaling Solutions. Anti-NCK1 and
anti-pS473 AKT mAbs were from BD Transduction Laborato-
ries andCell SignalingTechnology, respectively. Anti-M2, anti-
mLANA and anti-pY174 Vav1 rabbit polyclonal antibodies
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have been described (6, 17, 18). An anti-mLANAmAbwas gen-
erated against a GST-mLANA (residues 140–314) fusion pro-
tein at the EMBLMonoclonal AntibodyCore Facility. Anti-IgG
F(ab)2 fragments were from Jackson Immunoresearch. HRP-
conjugated Protein A and secondary antibodies were from GE
Healthcare and Jackson Immunoresearch.
Tissue Culture and Transfection—S11, A20, and Raji B cells
were grown in RPMI 1640 medium supplemented with 10%
FBS, 2 mM glutamine, and 100 units/ml penicillin and strepto-
mycin. SYF (19) and COS1 cells were grown in DMEM supple-
mented as above. A20 B cells were transfected by electropora-
tion as described (5). SYF cells were transfected with FuGENE
(Roche Applied Science).
Immunoprecipitation—5  107 S11 cells or 2  107 A20 B
cells transfected withM2 proteins for 24 h were disrupted with
ice-cold lysis buffer (10mMTris-HCl, pH 7.4, 150mMNaCl, 1%
Triton X-100, 1 mM NaVO4, 1 mM NaF, and Complete EDTA-
free protease inhibitors) and processed for immunoprecipita-
tion as described (5). Where indicated, A20 B cells expressing
eGFP proteins were isolated using a BD FACSaria flow cytom-
eter (BD Biosciences) prior to lysis.
Proteins—Proteins were expressed in Escherichia coli BL21
(DE3) pRARE2. GST fusion proteins were purified with gluta-
thione-Sepharose (GE Healthcare). For SPR experiments, the
GST partner was removed by protease cleavage to avoid avidity
effects due to dimerization of GST. Cleaved SH domains were
further purified and buffer-exchanged into HBS-EP (10 mM
Hepes, pH 7.4, 150 mMNaCl, 3 mM EDTA, 0.005% polysorbate
20) by gel filtration using a Superdex 75 10/300 GL column (GE
Healthcare). Single peaks corresponding to monomeric SH
domains were used in the SPR assays. His6-tagged proteins
were purified on nickel-nitrilotriacetic acid-agarose (Qiagen).
Surface Plasmon Resonance—These experiments were per-
formed with the Biacore 2000 system (GE Healthcare) at 25 °C.
Biotinylated pY120 and pY129 (Fig. 1A) and a biotinylated pep-
tide comprising the M2 C-terminal PRR (aa 153–171,
GPPTRPLPKLPNQHPMNPE; purchased from Sigma), named
M2(153–171), were diluted in HBS-EP and immobilized onto
streptavidin-coated sensor chip SA (GEHealthcare) to the indi-
cated response units (RU). Serial dilutions of the SH2 and SH3
proteins were prepared in HBS-EP and injected through pep-
tide and control blank cells. Dissociation was in running buffer,
and regeneration, if required, was achieved with a pulse injec-
tion of HBS-EP with 1 M NaCl. Bound protein was the differ-
ence between signal in peptide and in the control cells (supple-
mental Figs. S1 and S2). The equilibrium dissociation constant,
KD, was determined by non-linear fitting of the data using a 1:1
Langmuir isotherm.
Immunofluorescence—TransfectedA20B cells were added to
poly-L-lysine-coated coverslips (BD Biosciences), incubated for
30 min at room temperature, and processed for immunofluo-
rescence. SYF cells were grown on coverslips and transfected
for 48 h before fixation. Cells were fixed with 4% paraformalde-
hyde, PBS for 20 min at room temperature and permeabilized
for 10 min in 0.2% Triton X-100, PBS. Samples were stained
with primary antibodies for 1 h at room temperature followed
by detection with the indicated species-specific Alexa Fluor-
conjugated antibodies (Molecular Probes, Invitrogen). Fila-
mentous (F)-actin was stained with TRITC-phalloidin (Sigma),
and DNA was detected with DAPI (Invitrogen). PBS washes
were performed between all steps. Coverslips were mounted in
Mowiol (Fluka). Images were collected with a LSM 510 META
Zeiss confocal microscope using LSM 510 software and pro-
cessed with ImageJ.
RESULTS
Identification of Proteins InteractingwithTyrosine-phosphor-
ylated M2—We have employed a proteomic approach to iden-
tify cellular binding partners of tyrosine-phosphorylated M2.
Biotinylated peptides encompassing Tyr(P)120 or Tyr(P)129
(termed pY120 and pY129, respectively; see Fig. 1A) (5) were
used to pull down proteins from Raji B cell lysates. Peptide
complexes were precipitated with streptavidin beads, resolved
by SDS-PAGE, and stained with SYPRO Ruby (Fig. 1B). Pro-
teins that associated specifically with the peptides but not with
beads alonewere identified byMS. Vav1was identified in lane 2
(Fig. 1B and Table 1), confirming the interaction with pY120
(5). Similarly, the adaptor protein NCK1 and Lyn were exclu-
sively found in pY120 precipitates (Fig. 1B, lanes 2 and 4, and
Table 1). The association of a Src family kinase with pY120 is
not unexpected because we have shown before that Fyn binds
to this peptide (5). The PI3K regulatory  subunit (p85) pre-
cipitated in equivalent amounts with both pY120 and pY129
(Fig. 1B, lanes 2–4, and Table 1). PLC2, the tyrosine-protein
phosphatase SHP2, and the focal adhesion kinase FAK2 were
identified in pY129 precipitates only (Fig. 1B, lane 3, and Table
1). Tubulin and actin associated with pY120 or both peptides,
respectively (Fig. 1B, lanes 3 and 4, andTable 1), which could be
due to a nonspecific associationwith beads or to the presence of
cytoskeleton interacting proteins in the precipitates. Similar
pull-down experimentswere performedusingCOS1 cell lysates
(Fig. 1C). In this case, we identified NCK1, two ubiquitous Src
family kinases (Fyn and Yes), and the catalytic subunit of PI3K
(PK3CB) in pY120 precipitates, whereas PLC1, a non-hema-
topoietic isoform of PLC2, and SHP2 were found in associa-
tion with pY129 (Fig. 1C and Table 1). Vav1 was not detected in
these experiments because its expression is restricted to hema-
topoietic cells (20, 21). All identified proteins, except Vav1 and
Src family kinases, are previously unknown targets of M2.
Binding of M2 to SH2 Domains—Apart from FAK2, PK3CB,
and the cytoskeleton proteins, proteins found in pY120 and
pY129 precipitates contain one or two SH2 domains and, with
the sole exception of the SHP2, at least one SH3 domain (Fig.
2A). The SH2 domains of Vav1 and Fyn bind Tyr(P)120 (5).
Therefore, we next assessed if the cellular proteins identified
here also bound directly to theM2phosphomotifs via their SH2
domains.M2phosphopeptideswere used to pull-down individ-
ual SH2 domains expressed as GST fusion proteins in bacteria.
The GST-SH2 domains of Vav1 and Fyn were included as a
comparison. Binding of GST proteins to each peptide was
assessed by anti-GST immunoblots. All GST-SH2 proteins, but
not the non-chimeric GST, bound with varying strengths to at
least one of the phosphopeptides (Fig. 2B, first and second pan-
els from the top). The differences in binding were a reflection of
distinct selectivity because similar amounts of fusion proteins
were used in each pull-down (Fig. 2B, bottom). To explore fur-
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ther the global SH2 binding properties of the phosphopeptides,
we conducted binding analyses using SPR. The SH2 domains
with weaker association in the pull-down assays are likely to
contribute less to the interaction of the full-length proteins
with the phosphomotifs and were excluded from the analyses
(Fig. 2B, top panels, lanes 2, 4, and 7). M2 phosphopeptides
FIGURE1.A, schematic diagramof theM2proteindepicting Tyr120 andTyr129 and thepositionof theC-terminal PRR. The sequence containing Tyr120 andTyr129
differs from the consensus ITAM sequence (YXX(L/I)X6–8YXX(L/I)). Biotinylated phosphotyrosine peptidesmatching the sequence ofM2 between residues 114
and 126 (pY120) or between residues 123 and 135 (pY129) are shown. Tyrosine and Tyr(P) residues are highlighted in boldface type. Residues at positions1 to
3 relative to each tyrosine or phosphotyrosine that influence SH2 binding specificity are underlined. B and C, SYPRO Ruby-stained SDS-PAGE reducing gels
depicting proteins that interacted with M2 phosphopeptides. Lysates from the indicated cells were incubated with pY120 or pY129. Complexes were recov-
eredwith streptavidin-coupled agarose beads, andproteinswere resolved by SDS-PAGE and stainedwith SYPRORuby. As a negative control, lysateswere also
incubated with beads alone (B, lane 1). Molecular mass markers are depicted on the right in kDa. Arrows to the left of the lanes indicate bands identified by
MALDI-TOF. Asterisks denote bands for which no significant identity was obtained. In B, lane 3, PLC2 was identified in three bands denoted as a, b, and c. See
Table 1 for details on identification of the indicated bands. PD, pull-down.
TABLE 1
Identification of proteins that interacted with M2 tyrosine-phosphorylated peptides
Bands indicated by arrows in Fig. 1, B andC, were excised from the gels, digested with trypsin, and identified byMALDI-TOFmass spectrometry. MASCOT scores of54
(Raji B cells) or59 (COS1 cells) were considered significant (p 0.05).
Cells Peptide Lane Protein UniProtKB accession number
Theoretical
molecular mass
Identified
peptides Coverage
MASCOT
score
kDa %
Raji B cells pY120 2 Vav1 P15498 99 11 13 87
p85 P27986 83 11 13 86
NCK1 P16333 43 18 51 216
pY129 3 PLC2(a) P16885 149 17 16 126
PLC2(b)/FAK2 P16885/Q14289 149/117 18/16 13/20 110/105
PLC2(c) P16885 149 14 11 122
p85 P27986 83 12 15 108
SHP2 Q06124 68 22 35 254
/-Actin P60709/P63261 42/42 10/10 37/37 122/122
pY120 4 p85 P27986 83 17 23 184
Lyn P07948 58 15 34 215
-Tubulin P07437 50 7 19 72
NCK1 P16333 43 14 32 173
/-Actin P60709/P63261 42/42 14/14 42/42 229/229
COS1 cells pY120 1 PK3CB P42338 124 23 27 243
Yes/Fyn P07947/P39688 61/60 24/24 20/13 106/60
-Actin/NCK1 P60712/P16333 42/43 13/13 46/38 112/103
pY129 2 PLC1 P19174 149 19 19 177
SHP2 Q06124 68 16 30 173
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were immobilized on a streptavidin chip, and binding to puri-
fied SH2 domains (Fig. 2C) was probed at a range of concentra-
tions. In parallel, the signal from a control blank channel in the
same chip was measured and subtracted from that of each pep-
tide channel to give bound protein. Binding data were charac-
teristic of interactions with rapid kinetics (supplemental Fig.
S1) and enabled determination of the KD value by non-linear
fitting of binding values at equilibrium (Fig. 2D; listed in Table
2). The SH2 domains of Vav1, NCK1, and Src family kinases
Fyn and Lyn bound preferentially to pY120with strong tomod-
erate affinity (118 nM to 5 M) and much more weakly to
pY129 (1–17 M). These results explain why, at lower protein
concentrations, such as those in cell extracts, we only detected
association of the full-length proteins with pY120 (Fig. 1, B and
C). TheC-terminal SH2 domain of p85 boundwith equivalent
affinity (2 M) to both phosphopeptides, and the N-terminal
SH2 domain of SHP2 bound weakly (12.279 M) to Tyr(P)129
and nearly undetectably to Tyr(P)120 (Fig. 2D and supplemental
Fig. S1). These results agree with pull-down data (Fig. 1, B and
C). The C-terminal SH2 domain of PLC2 bound strongly (179
nM) to pY129 and, surprisingly, with a similar albeit slightly
lower affinity to pY120 (252 nM).
M2 Assembles Multiprotein Complexes in B Cells—We next
conducted immunoprecipitation experiments to assess if M2
associatedwith PLC2, p85, SHP2, andNCK1 in B cells and to
determine which M2 motifs would be involved in the interac-
tions.Myc-tagged wild typeM2 ormutant proteins with Tyr120
and/or Tyr129 replaced by phenylalanine (Y120F, Y129F, and
Y120F/Y129F (M2Y) mutants) were transiently expressed in
A20 B cells. We included in our analysis M2P2, an M2 mutant
protein that has theC-terminal PRRdisrupted and binds poorly
to Vav1 (6). PLC2, p85, SHP2, and NCK1 were immunopre-
cipitated from cellular extracts, and bound M2 proteins were
detected by anti-Myc immunoblots. Wild type and Y129F pro-
teins associated in equivalent amountswith all immunoprecipi-
tated proteins (Fig. 3, A–D, top panels, lanes 2 and 5). This
association was dramatically reduced in the case of M2Y and
M2P2 (Fig. 3, A–D, top panels, lanes 3 and 6). Disruption of
Tyr120 had no effect on binding of M2 to PLC2 but greatly
diminished the interaction of the viral protein with the other
cellular targets (Fig. 3, A–D, top panels, lane 4).
To determine ifM2 formedmultiprotein complexes with the
proteins identified here, PLC2 immunoprecipitates were
probed for the presence of the other M2 cellular targets. In
the presence of wild type or the Y129FM2 protein, NCK1, Fyn,
p85, and Vav1 co-immunoprecipitated with PLC2 (Fig. 3A,
top panels, lanes 2 and 5). SHP2 was not detected in these pre-
cipitates. In parallel Tyr(P) immunoblots, we assessed the phos-
phorylation of proteins in all of the above immunoprecipitates.
Although phosphorylation of p85, NCK1, and SHP2 was
undetectable in all experimental conditions (data not shown),
PLC2 was consistently phosphorylated upon expression of
wild typeM2 (Fig. 3A, top, lane 2). As described before (5), wild
type and Y129FM2 proteins and co-immunoprecipitated Vav1
were all tyrosine-phosphorylated (Fig. 3A, second and third
panels from top, lanes 2 and 5). M2 therefore assembles a range
of complexes with PLC2, p85, NCK1, Vav1, Src family tyro-
sine kinases, and SHP2 in B cells. The Tyr(P)120 motif is
required for the formation of M2 complexes containing Vav1,
Fyn, NCK1, and p85 and to drive phosphorylation of Vav1.
Either Tyr(P) motif is sufficient to allow association ofM2 with
PLC2, but both motifs are needed to drive phosphorylation of
PLC2. Pull-down assays using GST-M2 and His-tagged SH3
domains revealed that the SH3 domains of PLC2, p85, and
NCK1 do not bind directly toM2 (supplemental Fig. S3). Thus,
unlike Vav1, Fyn and Lyn, which bind M2 via SH3 and SH2
domains, direct binding of PLC2, p85, NCK1, and SHP2 to
M2 occurs solely via Tyr(P)-SH2 interactions. The decreased
interaction of the latter proteins with M2P2 (Fig. 3, A–D, lane
6) could be due to lower phosphorylation levels of this mutant
(5, 6).
Immunoprecipitation experiments in murine B lymphoma
S11 cells, which are predominantly infected with latent
MuHV-4 (22), revealed that M2 co-immunoprecipitated with
PLC2 and p85 (Fig. 3, E and F, top panels, lane 2). Immuno-
precipitation with an unrelated antibody against a key latency-
associated viral protein, mLANA, did not yield detectable M2
(Fig. 3, E and F, top panels, lane 1). Therefore, in a context of
infection and endogenous M2 expression, M2 associates with
both of these enzymatic targets.
FIGURE 2. SH2 domains bind each of the M2 phosphomotifs with different affinities. A, schematic diagram of SH2-containing proteins identified by MS.
Gray rectangles, SH2 domains; dark gray ellipses, SH3 domains. Other represented domains are pleckstrin homology (PH), elongation factor-hand (EF), phos-
pholipidbinding (C2), PLC2 catalytic domains (X andY), bipartite PH (PH/), calponinhomology (CH), guanidine exchange factor (GEF) catalytic domainof Vav1,
zinc finger (ZF), break point homology (BH), and p110 binding domain (p110BD). B, pull-down of GST or GST-SH2 fusion proteins with pY120 (top) or pY129
(middle). GST fusion proteins were incubated with the biotinylated peptides, and the peptide complexes were captured with streptavidin-Sepharose beads.
Precipitated proteins were detected by anti-GST immunoblotting. An aliquot of the purified recombinant proteins was also analyzed by Western blot to
demonstrate that similar amounts of each proteinwere used in the pull-downs (bottom). The positions ofmolecular sizemarkers are indicated to the left of the
panels. C, Coomassie Blue-stained SDS-PAGE gel depicting the purified SH2 domains used in the SPR experiments. M, molecular weight markers. D, binding
affinityof SH2domains forM2phosphomotifs asdeterminedbySPR. The indicatedSH2domainswere injectedat 5–10l/min for 1–3minover empty flowcells
or cells containing immobilized pY120 (30 RU) or pY129 (25 RU). At each concentration, bound protein was the difference between the response at
equilibrium between the peptide and empty flow cells. The equilibrium dissociation constant, KD, was calculated by non-linear fitting of the equilibrium
binding data. With the exception of the Lyn SH2-pY129 interaction, data are representative of at least two independent experiments. PD, pull-down; WB,
Western blot; N, N-terminal SH2 domain; C, C-terminal SH2 domain.
TABLE 2
Affinity of SH2 domains for M2 tyrosine-phosphorylated peptides
ND, not determined; N, N-terminal SH2 domain; C, C-terminal SH2 domain; n,
number of experiments performed.
SH2
domain
pY120 pY129
Mean
KD
KD
range n
Mean
KD
KD
range n
M M M M
Fyn 0.118 0.113–0.126 3 1.086 1.059–1.112 2
PLC2 C 0.252 0.232–0.273 2 0.179 0.165–0.192 2
Lyn 0.796 0.627–0.911 3 3.821 1
NCK1 0.887 0.782–0.981 4 6.048 5.139–6.555 3
p85 C 2.471 2.464–2.477 2 2.662 2.885–2.438 2
Vav1 5.412 4.950–6.838 4 17.166 15.565–18.829 3
SHP2 N ND ND 2 12.279 12.164–12.393 2
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M2 Drives Tyrosine Phosphorylation of PLC2 at Activation
Sites and Inhibits AKT upon BCRActivation—Upon BCR stim-
ulation, phosphorylation of PLC2 occurs atTyr753, Tyr759, and
C-terminal Tyr1197 and Tyr1217 (23–27). Phosphorylation of
Tyr753 and Tyr759 correlates with PLC2 activation (24–26,
28). To identify the sites ofM2-driven PLC2 phosphorylation,
we used a series of tyrosine to phenylalanine mutants targeting
these four sites (Fig. 4, A and B). The HA-tagged mutants or
wild type PLC2 were expressed alone or together with wild
type M2 in A20 B cells. PLC2 proteins were immunoprecipi-
tated with an anti-HAmAb, and phosphorylation was assessed
byTyr(P) immunoblots.M2expressiondrove robust phosphor-
ylation of transfected wild type PLC2 (Fig. 4, A and B, top
panel, lane 4), confirming results observed with endogenous
protein (Fig. 3A, top, lane 2). All PLC2 mutants displayed
diminished phosphorylationwhen comparedwith thewild type
protein, indicating that all four sites are phosphorylated upon
M2 expression (Fig. 4, A and B, top panels). Notably, this
decrease was higher in the PLC2 C-terminal mutants, which
suggests that Tyr1197 and Tyr1217 are favored phosphorylation
sites. All PLC2 proteins were expressed in equivalent amounts
(Fig. 4, A and B, bottom panels).
To assess the effect ofM2 binding to p85 onPI3Kpathways,
we investigated the activation status ofAKT, a serine/threonine
kinase that is a downstream effector of PI3K, upon M2 expres-
sion. PI3K activation leads to the production of PIP3 and
recruitment of AKT to the plasma membrane via its pleckstrin
homology domain (29). Membrane anchorage is required for
phosphorylation of AKT on Ser473 and its full activation (30).
Expression of eGFP-tagged M2 in A20 B cells inhibited trans-
location of the mCherry-tagged PH-AKT to the plasma mem-
brane upon BCR stimulation (Fig. 5, A (middle panels) and B).
This effect was dependent on the phosphorylation of M2,
because it was reverted when the eGFP-M2Y mutant protein
FIGURE 3.M2 assembles multiple signaling complexes in B cells. A–D, A20 B cells transiently expressing Myc-tagged wild type (WT) or the indicated M2
mutant proteins were lysed, and cleared lysates were incubatedwith anti-PLC2 (A), anti-p85 (B), anti-NCK1 (C), or anti-SHP2 (D) antibodies. Immunoprecipi-
tates (top panels) were analyzed byWestern blotting with specific antibodies against Vav1, NCK1, Fyn, p85, PLC2, SHP2, or Tyr(P), and an anti-Myc antibody
was used to detect M2 proteins (top panels). Anti-Myc immunoblots were performed in an aliquot of the total cellular lysates to confirm ectopic expression of
M2proteins (bottompanels). Tyrosine-phosphorylatedPLC2, Vav1, andM2aredenotedaspPLC2,pVav1, andpM2, respectively. E and F, lysates fromS11 cells
werepreclearedwithProteinG-Sepharosebeads and then incubatedwith rabbit anti-mLANAor anti-PLC2 IgG (E) orwith rabbit anti-mLANAor anti-p85 sera
(F). Immunocomplexes, captured with Protein G-Sepharose beads, and an aliquot of the total cellular lysates were resolved by SDS-PAGE and analyzed by
Western blotting using anti-PLC2 (E) or anti-p85 (F) polyclonal antibodies and an anti-mLANAmAb. To identifyM2, a rabbit polyclonal anti-M2 antibodywas
used, followedbydetectionwithHRP-conjugated Protein A instead of a secondary antibody, in order to diminish signal derived from light chains of antibodies
used in the immunoprecipitation (toppanels).Arrows to the leftof thepanels indicate thebandcorresponding toM2. IP, immunoprecipitation; TCL, total cellular
lysates.
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was expressed (Fig. 5, A (bottom panels) and B). Consistently,
expression of wild type M2, but not the M2Y protein, in A20 B
cells prevented phosphorylation of AKT on Ser473, an effect
evident after BCR stimulation (Fig. 5C, top).
Juxtamembrane Localization of M2 Depends on the C-termi-
nal PRR SH3 Binding Motif and Src Family Kinase Expression—
M2 localizes to the nucleus and in juxtamembrane actin-rich
areas of the cytoplasm in fibroblasts and predominantly near
the plasma membrane in B cells (6, 9, 11). To assess if the M2
SH3 and SH2 binding sites had a role in determining its subcel-
lular localization, we examined the distribution of eGFP-tagged
M2 proteins in A20 B cells (Fig. 6A). All eGFP-M2 proteins
expressed in equivalent amounts, and wild type M2 and Y129F
proteins drove phosphorylation of Vav1 (Fig. 6B). Thus, the
FIGURE 4.M2 induces tyrosine phosphorylation of PLC2 at activation sites.A and B, A20 B cells were transfectedwith plasmids encodingHA-taggedwild
type (WT) PLC2or tyrosine tophenylalaninemutant versions of PLC2, aloneor togetherwithpCMV-mycwild typeM2. ThePLC24YFproteinhas compound
tyrosine to phenylalanine mutations of Tyr753, Tyr759, Tyr1197, and Tyr1217. Twenty-four hours after transfection, cell extracts were prepared and subjected to
immunoprecipitation with a rabbit polyclonal anti-HA antibody. Immunocomplexes were resolved by SDS-PAGE and analyzed by Western blotting with
anti-Tyr(P) and anti-PLC2 antibodies (top panels). Tyrosine-phosphorylated PLC2 is denoted as pPLC2. An aliquot of the total cellular lysates was also
analyzed by Western blot using anti-Myc antibodies to confirm expression of M2 in the appropriate samples (bottom panels). Anti-actin immunoblots con-
firmed that equivalent amountof cellular extractswereused in eachexperimental condition (bottompanels)., without;, with; IP, immunoprecipitation; TCL,
total cellular lysates.
FIGURE 5.M2expression inhibits AKT translocation to the plasmamembrane and its phosphorylation upon BCR stimulation. A, A20 B cells expressing
the mCherry-tagged PH domain of AKT and eGFP (two top panels), eGFP-tagged wild type (WT) M2 (two middle panels), or M2Y (two bottom panels) were
unstimulated () or stimulated () with 10 g/ml anti-IgG F(ab)2 for 5 min. B, quantification of mCherry-PH-AKT translocation to the plasma membrane as
observed in A. Bars, mean percentage of co-transfected cells where PH-AKT localized at the plasma membrane. Error bars, S.D. value of three independent
experiments. In each experiment, 100 doubly transfected cells/conditionwere scored. C, M2 expression reduces phosphorylation of AKT on Ser473. A20 B cells
transiently expressing eGFP-tagged wild type (WT) M2 or the M2Ymutant protein were sorted by flow cytometry 24 h after transfection. Cells were unstimu-
lated () or stimulated () as in A and lysed, and an aliquot of the total cellular lysates was analyzed byWestern blot analysis using specific antibodies against
phospho-Ser473 (pS473) AKT, AKT, M2, and actin.
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eGFP tag did not interfere with M2 function. Wild type M2
predominantly co-localized with actin near the plasma mem-
brane (90% of transfected cells; Fig. 6, A (top panels) and C)
and to a much lesser extent in the nucleus. The tyrosine
mutants had a distribution similar to that of the wild type pro-
tein (Fig. 6, A (three middle panels) and C). The M2P2 protein,
however, seldom localized near the plasma membrane (less
than 5% of transfected cells; Fig. 6C) and was mainly found in
the nucleus (Fig. 6A, bottom panels). As expected, both wild
type M2 and the Y129F protein co-localized with Vav1 and
drove its phosphorylation (Fig. 6, A and B). PP2, an Src family
kinase inhibitor, but not PP3, its inactive homologue, inhibited
the phosphorylation ofM2 inA20B cells but hadno effect on its
subcellular localization (Fig. 6, D and E). Thus, the juxtamem-
branar localization ofM2 is independent of its phosphorylation
status or Src family tyrosine kinase activity. In contrast, the
C-terminal PRR is required to concentrate M2 near the plasma
membrane, possibly by mediating binding to an SH3-contain-
ing protein.
Immunoprecipitation experiments have shown that the M2
C-terminal PRR modulates the interaction of M2 with Fyn (6).
However, evidence of direct binding of this region of M2 to the
FIGURE 6. TheC-terminal SH3bindingmotif ofM2determines juxtamembrane localization in B-cells.A, A20 B cells expressing eGFP-taggedwild type or
the indicated M2 mutant proteins. F-actin was stained with TRITC-phalloidin, and active Vav1 was detected with an anti-pY174 Vav1 antibody and an Alexa
Fluor 647-conjugated secondary antibody. B, Western blot analysis of A20 B cell lysates expressing the indicated proteins. eGFP and eGFP-taggedM2 proteins
were detectedwith an anti-GFP antibody, total Vav1was detectedwith anti-Vav1, and active Vav1was detectedwith anti-pY174Vav1.C, quantification of cells
with juxtamembrane localization of M2 proteins. Bars, mean percentage of transfected cells where wild type or M2mutant proteins localized near the plasma
membrane. Error bars, S.D. value of three independent experiments. In each experiment, 100 transfected cells/condition were scored for juxtamembrane
localization of M2. D, localization of eGFP-tagged wild type M2 in A20 B cells incubated for 30 min at 37 °C with 20 M Src family kinase inhibitor PP2 or its
inactive analog, PP3. F-actin was stained with TRITC-phalloidin, and tyrosine phosphorylation was detected with an Alexa Fluor 647-conjugated anti-Tyr(P)
antibody. E,Westernblot analysis of Fyn tyrosinephosphorylation inA20B cells treatedwithPP2andPP3as inD.Mock-transfected cells or cells expressingwild
type eGFP-taggedM2were lysed, and the cleared lysateswere subjected to immunoprecipitationwith an anti-Fyn antibody, followedbyWesternblot analysis
with an anti-Tyr(P) antibody (top panel, top arrow). Anti-Fyn immunoblots were performed to confirm equivalent levels of immunoprecipitated Fyn in each
condition (second panel from top). An aliquot of the total cellular lysates was analyzed byWestern blot using an anti-Tyr(P) antibody (third panel from top) and
an anti-GFP antibody (bottompanel). Tyr(P) bands corresponding to phosphorylated Fyn (pFyn) or consistentwith the size of eGFP-taggedphosphorylatedM2
(pM2) are indicated by arrows on the left side of the panels., without;, with; IP, immunoprecipitation; TCL, total cellular lysates.
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SH3 domains of Src family kinases is lacking. SPR analyses
revealed that a synthetic peptide comprising the C-terminal
PRR of M2 bound the purified SH3 domains of Fyn and Lyn,
with a higher affinity for the SH3 domain of Lyn (Fig. 7, A and
B). Notably, the affinity values obtained are strikingly close to
those observed between the SH3 domains of these kinases and
proline-rich peptides derived from the cytoplasmic tails of K15,
Tip, andTio, all transmembrane signaling proteins from simian
-herpesvirus (31–33). Because active Src family kinases local-
ize in actin-rich membrane ruffles (34), we hypothesized that
Fyn or Lyn could be recruitingM2 to the plasmamembrane. To
address this issue, we investigated the localization of eGFP-
taggedM2 proteins in SYF fibroblasts, which lack Src, Yes, and
Fyn, the ubiquitously expressed Src kinases (19).Wild typeM2,
M2Y, andM2P2 localized predominantly in the nucleus of SYF
cells (Fig. 7C). However, upon co-expression with Fyn, wild
type M2 and M2Y localized in the nucleus and in membrane
ruffles, whereas theM2P2 protein remained exclusively nuclear
(Fig. 7D). Thus, Src family kinases are required for the jux-
tamembrane localization of M2 possibly by directly recruiting
the viral protein.
DISCUSSION
In this work, we have expanded the set of binding partners of
phosphorylated M2 and show that, in addition to the Tyr(P)120
motif, the motif encompassing Tyr(P)129 also targets SH2
domains. By screening the cellular proteins associating with
pY120 and pY129 peptides by MS, we identified new interac-
tions between M2 and PLC2, p85, adaptor protein NCK1,
and the SHP2 phosphatase. Each phosphomotif of M2 consti-
tutes a specific, independent interaction region for the different
full-length proteins. The Tyr(P)120 motif interacted with Fyn,
Lyn, Vav1, and NCK1; the Tyr(P)129 motif associated with
PLC2 and SHP2; and both phosphomotifs interacted equally
with p85. Direct association of the cellular proteins with the
M2phosphomotifswasmediated by SH2domains. The binding
affinities of the individual SH2 domains for each phosphomotif
varied from100 nM (strong binding) to17 M (weak bind-
ing), which is within the affinity range of 100 nM to 10 M
described for SH2-Tyr(P) interactions (35). Direct binding
analyses revealed additional overlapping specificities, as is the
case for the SH2 domains of Fyn, Lyn, Vav1, and NCK1 that
bound both phosphomotifs despite having a greater affinity for
pY120. Within the subset of proteins containing dual SH2
domains, our results indicate that the C-terminal SH2 domains
of PLC2 and p85 and the N-terminal SH2 domain of SHP2
mediate direct association of the full-length proteins with M2
phosphosites. Given that PLC2 associated abundantly and
exclusively with pY129, we were surprised that its C-terminal
SH2 domain bound tightly to both phosphopeptides. It is pos-
sible that association of PLC2 with pY129 was enhanced by
indirect interactions or that, in the context of the full-length
protein, the affinity of its C-terminal SH2 domain for pY129 is
higher than that of the isolated domain. Consistent with this
idea, other results have shown that Vav1 and PLC family
members interact physically and functionally in lymphoid cells
(36). All other binding affinities correlated with the specificity
of the full-length proteins for M2 phosphopeptides.
M2 expression drove robust tyrosine phosphorylation of
PLC2 in B cells. By analogy to theM2-Fyn-Vav1 complex that
drives Vav1 phosphorylation, M2 may also act as an adaptor
toward PLC2, bringing it into the vicinity of an Src family
kinase and promoting its phosphorylation. Corroborating this
idea is the fact that Fyn co-immunoprecipitates with PLC2
and M2. Both M2 phosphomotifs were required to induce
phosphorylation of PLC2, suggesting that the Tyr(P)129 motif,
despite having lower levels of phosphorylation than the
Tyr(P)120 motif (5), works as an effective SH2 docking site. The
pattern of M2-driven PLC2 tyrosine phosphorylation is simi-
lar to that induced by BCR stimulation and indicates thatM2 is
activating the PLC2 pathway, but this needs further confirma-
tion. Similarly, K1 also induces constitutive tyrosine phosphor-
ylation of PLC2. Although the phosphorylation sites have not
been identified, K1 was shown to activate the PLC2 pathway
(3, 37). TheC-terminal Tyr residues of PLC2 appeared to have
a higher contribution to the total phosphorylation of the pro-
tein uponM2 expression. Phosphorylation of Tyr753 andTyr759
predominantly depends on Btk/Tec kinases and correlates with
the catalytic activation of PLC2 (23, 24, 26, 38). Phosphoryla-
tion of Tyr1197 and Tyr1217 is largely Btk-independent and is
likely to depend on Src family kinases, but its role in PLC2
signaling is unclear (23, 25, 26). The close association of M2
with Src family kinases may favor phosphorylation on these
C-terminal residues.
Surprisingly,M2 expression had an inhibitory effect onAKT.
This suggests that M2 may inhibit PI3K activity and contrasts
with the effect of K1, LMP1, and LMP2A, which activate the
PI3K/AKTpathway (39–41). Thus, it is possible that the inhib-
itory effect exerted on PI3K by M2 may be compensated by
selective activation of PLC2 and Vav1. Similar to M2, p85
contains a proline-rich peptide that binds the SH3 domains of
Fyn and Lyn. This interaction leads to increased catalytic activ-
ity of the PI3K (42). The inhibitory effect ofM2 could be simply
due to competition, by preventing the SH3domains of those Src
family tyrosine kinases from binding p85 and activating PI3K.
However, theM2double tyrosine to phenylalaninemutant pro-
tein failed to inhibit AKT activation, indicating that M2 phos-
phorylation is required for this effect (Fig. 5, A–C). Another
possiblemechanism for theM2 inhibition of AKTwould be the
sequestration of the p85 by M2 through Tyr(P)-SH2 interac-
tions, which could prevent activation of PI3K.
The C-terminal PRR ofM2 has several roles inM2 signaling.
First, it mediates robust association with Vav1, a main target of
M2 in several ectopic expression systems (5, 6). Second, it is
required for tyrosine phosphorylation of M2 to create addi-
tional docking sites on the protein. Here, this region of M2 is
shown to bind directly and strongly, within the known affinity
range of SH3 domains for proline-rich regions (43), to the SH3
domains of Fyn and Lyn. Both this C-terminal PRR and Src
family kinase expression are required to concentrate M2 near
the plasma membrane. These results support a model in which
direct association of M2 with Src family kinases via a C-termi-
nal PRR-SH3 interactionwould recruitM2 to the plasmamem-
brane and lead to its phosphorylation. The predominance of
M2 at the plasma membrane in B cells could be due to the
presence of specific Src family kinases. BecauseM2 localization
Interaction ofM2with SH2 and SH3Domains
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FIGURE 7. Localization of M2 to membrane ruffles is dependent on the expression of Src family tyrosine kinases. A, Coomassie Blue-stained SDS-
polyacrylamidegel depicting thepurified SH3domains used in SPRexperiments.M,molecularweightmarkers.B, theC-terminal PRRofM2bindsdirectly to the
SH3domains of Lyn and Fynwith distinct affinities. The SH3domains of Fyn and Lynwere injected at a range of concentrations, at 10l/min, over immobilized
M2(153–171) peptide (140 RU) or an empty control cell. Equilibrium binding values were plotted against analyte concentration, and the KD value was
determined by non-linear fitting of the data. Data are representative of two independent experiments. C, localization of eGFP-tagged wild typeM2, M2Y, and
M2P2 proteins transiently expressed in SYF cells. F-actin was detected with TRITC-phalloidin. D, SYF cells ectopically expressing HA-tagged Fyn and eGFP-M2
proteins. Fyn was detected with an anti-HA primary antibody followed by staining with an Alexa Fluor 594-conjugated secondary antibody.
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in B cells is independent of Src family kinase activity, it is likely
that the kinase is directly recruiting M2 rather than indirectly
affecting M2 localization through phosphorylation of a bridge
protein or modulation of the actin cytoskeleton. Upon tyrosine
phosphorylation, M2 forms a wider range of complexes, a pro-
cess that is probably regulated by the level of M2 phosphoryla-
tion, the local concentration and conformation of the cellular
partners, and the affinity of their SH2 and SH3 domains forM2.
The M2 sequence encompassing Tyr120 and Tyr129 does not
form a consensus ITAM (Fig. 1A). However, there are similar-
ities, such as the close proximity between the tyrosine residues
and similar sequence identity of the Tyr129 motif (Y129IQP) to
the second motif of the K1 ITAM (YTQP) (44). We propose
thatM2encodedbyMuHV-4, like LMP1, LMP2A,K1, andK15,
modulates B cell signaling, but contrary to the latter proteins, it
is a soluble cytoplasmic protein with a juxtamembranar local-
ization that recruits SH2-containing cellular proteins through
an unconventional ITAM.
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